Profile Pic of Mediterranean Journal Of Pharmacy And Pharmaceutical Sciences Mediterranean Journal Of Pharmacy And Pharmaceutical Sciences

Hypotensive effect of yeast in the hypertensive rat model

  • Authors Details :  
  • Aisha M. Alfituri ,  
  • Faiza A. Elhamdi ,  
  • Salwa M. Alfituri ,  
  • Abubaker A. Bashir ,  
  • Ahmed F. Behriz ,  
  • Awad G. Abdellatif

271 Views Original Article

Elevated arterial blood pressure is the most important public health problem in developed countries. It often leads to lethal complications if left untreated. Brewer's yeast is celebrated for its various beneficial effects, including a possible hypotensive effect. Thus, the anti-hypertensive effects of brewer’s yeast were investigated. The hypertensive model was done by a once-weekly intraperitoneal injection of dexamethasone at a dose of 25 mg/kg combined with drinking a 1.0% sodium chloride solution containing 0.2% KCl and 2.0% glucose for six weeks. The blood pressure was measured by the rat carotid artery cannulation preparation. Different doses of brewer's yeast dissolved in distilled water were injected into the internal jugular vein, with measurement of blood pressure at each time. To explore the mechanism of the hypotensive effect of yeast, the yeast cardiac effect was verified by the use of isolated perfused rabbit heart preparations using different antagonists. It was found that dexamethasone elevated systolic blood pressure to 178.3±11.6 and diastolic blood pressure to 133.3±16.6 from normal levels of 115.0±9.1 for systolic and 74.0±4.1 for diastolic. The gradual increase in intravenous yeast doses ranging from 0.05 to 0.40 effectively lowered systolic and diastolic blood pressure in rats with normal pressure, bringing them to approximately 80.0±05.6 mmHg for systolic and 40.0±3.5 mmHg for diastolic. While doses exceeding 0.04 resulted in a drop in systolic pressure to 60.0±3.9 mmHg, diastolic pressure became unrecordable. The administration of the 0.20 dose resulted in unrecordable blood pressure. In hypertensive rats, a decrease in blood pressure was observed with doses ranging from 0.60-1.0 mg, leading to a reduction to 110.0±2.8 mmHg for systolic and 52.0±9.9 mmHg for diastolic pressures. Doses exceeding 1.0 mg further lowered systolic and diastolic pressures to 20.0±3.9 mmHg. There was a mild increase in heart rate with no change in cardiac force of contraction. This effect was not mediated through beta, calcium receptors, or the histamine effect. The findings show that the yeast has a dose-dependent blood pressure-lowering effect. The mechanism of the chronotropic effect is possibly due to its direct action.

Article Subject Details


Article Keywords Details



Article File

Full Text PDF





More Article by Mediterranean Journal of Pharmacy and Pharmaceutical Sciences

The perspective of covid-19 vaccines

The current covid-19 is now endemic on everycontinent and becomes the most challenging outbreaks over centuries, thus millions of people have been infected with the novel coronavir...

Mokhtar r. haman: a dedication to his memory

It is with more sorrow and tremendous sadness we remember the death of our colleague the libyan pharmacist, professor mokhtar ramadan haman, at his home in tripoli, libya after lon...

In silico studies of 2-(4-(aminomethyl)phenyl)isoindoline-1,3-dione schiff base derivatives as potential inhibitors against main protease covid-19 enzyme

The 2019 coronavirus (covid-19) pandemic is spreading worldwide, with a spectacular increase in death missing any effective therapeutic treatment up to now. molecular docking is a ...

Phytochemical screening and structure elucidation of isolated compounds from convolvulus dorycnium plant originated from west of libya

Plants are an ancient source of medicine due to the presence of bioactive molecules of various compounds in their different parts. convolvulus dorycnium plant belongs to the family...